Efectividad, seguridad y aceptabilidad del tratamiento con teriflunomida en pacientes con esclerosis múltiple recurrente-remitente en el Hospital Universitario Central de Asturias (Oviedo) que iniciaron tratamiento en 2015.

Antonio Sanz Diaz; Leticia Gómez De Segura Iriarte

EFECTIVENESS, SAFETY AND ACCEPTABILITY OF TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS WHO STARTED TREATMENT AT HOSPITAL UNIVERISTARIO CENTRAL DE ASTURIAS (OVIEDO) IN 2015.

Antonio Sanz Diaz

Universidad de Salamanca asanzdiaz[at]usal.es
Leticia Gómez De Segura Iriarte

ospital Universitario Central de Asturias

Download

+ −

Metrics

84 Views

93 Downloads

177 Total

How to Cite

Sanz Diaz, A., & Gómez De Segura Iriarte, L. (2017). EFECTIVENESS, SAFETY AND ACCEPTABILITY OF TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS WHO STARTED TREATMENT AT HOSPITAL UNIVERISTARIO CENTRAL DE ASTURIAS (OVIEDO) IN 2015. FarmaJournal, 2(2), 107–115. Retrieved from https://revistas.usal.es/cinco/index.php/2445-1355/article/view/16018

Download Citation

Editorial dates

Submitted:

2017-04-07

Acceptance:

2017-04-07

Issue

Vol. 2 No. 2 (2017)

Section

Research Reports

Keywords

Teriflunomide
relapsing-remitting multiple sclerosis
effectiveness
safety
acceptability.

Supporting agencies

This research didn't have any funding